To determine if the variable p53 function observed during the course of treatment with sunitinib affected the levels of α(II) PH, endostatin and arresten, the tumor lysates from Figure 1 were analyzed by western blot for these proteins. This evidence concerns the gene COL18A1 and neoplasm.